Fosun Pharmaceutical (01652.HK): Injectable Chloroquine Phosphate Receives Approval for Market Launch

The Chitoo Finance APP announced that Fosun Pharmaceutical (01652.HK) has released a statement. The company's wholly-owned subsidiary, Jiaheng (Zhuhai Hengqin) Pharmaceutical Technology Co., Ltd., has developed "Chloroxycan for Injection," and its application for listing has been approved by China's National Medical Products Administration. It is approved for short-term treatment of acute moderate pain after surgery.